WY14,643, a PPARα ligand, attenuates expression of anti-glomerular basement membrane disease

Peroxisome proliferator-activated receptor alpha (PPARα) ligands are medications used to treat hyperlipidaemia and atherosclerosis. Increasing evidence suggests that these agents are immunosuppressive. In the following studies we demonstrate that WY14,643, a PPARα ligand, attenuates expression of an...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Archer, D C, Frkanec, J T, Cromwell, J, Clopton, P, Cunard, R
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Publishing Ltd 2007
Teme:
Basic Immunology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2219353/
https://ncbi.nlm.nih.gov/pubmed/17888025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2249.2007.03505.x
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items